¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"dorsolateral nucleus of oculomotor nuclear complex"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • dyad nucleus
    À̺ÐÀÚÇÙ
  • dentate nucleus
    Ä¡¾ÆÇÙ
  • dorsal nucleus of thalamus
    ½Ã»óµîÂÊÇÙ, ½Ã»ó¹èÇÙ
  • Edinger-Westphal nucleus
    ¿¡µù°Å-º£½ºÆ®ÆÈÇÙ, µ¡´«µ¹¸²½Å°æÇÙ
  • emboliform nucleus
    ¸¶°³ÇÙ, Àü»óÇÙ
  • fastigial nucleus
    ²ÀÁöÇÙ
  • facial nucleus
    ¾ó±¼½Å°æÇÙ, ¾È¸é½Å°æÇÙ
  • fertilization nucleus
    ¼öÁ¤ÇÙ
  • flat nucleus
    ÆíÆòÇÙ
  • free nucleus
    À¯¸®ÇÙ
  • fusiform nucleus
    ¹æÃßÇÙ, ¹æÃß»óÇÙ
  • geniculate nucleus
    ¹«¸­ÇÙ, ½½»óÇÙ
  • gigantocellular nucleus
    °Å´ë¼¼Æ÷ÇÙ
  • globose nucleus
    µÕ±ÙÇÙ
  • gracile nucleus
    ³ÎÆÇÇÙ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • fusiform nucleus
    ¹æÃßÇÙ
  • geniculate nucleus
    ¹«¸­ÇÙ
  • gigantocellular nucleus
    °Å´ë¼¼Æ÷ÇÙ
  • globose nucleus
    µÕ±ÙÇÙ
  • gracile nucleus
    ³ÎÆÇÇÙ
  • habenular nucleus
    °í»ßÇÙ
  • hyperchromatic nucleus
    °ú´Ù¿°»öÇÙ
  • hypoglossal nucleus
    Çô¹Ø½Å°æÇÙ
  • hypothalamic nucleus
    ½Ã»óÇϺÎÇÙ
  • infundibular nucleus
    Ȱ²ÃÇÙ
  • intermitotic nucleus
    ºÐ¿­»çÀ̱âÇÙ
  • interpeduncular nucleus
    ´Ù¸®»çÀÌÇÙ
  • interstitial nucleus
    »çÀÌÁúÇÙ
  • intralaminar reticular nucleus
    ¼¶À¯ÆÇ¼Ó±×¹°ÇÙ
  • lacrimal nucleus
    ´«¹°ºÐºñÇÙ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • red nucleus =n. ruber
    ÀûÇÙ(îåú·).
  • reniform nucleus
    ÄáÆÏÇÙ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • nuclear vesicle
    ÇÙ¼ÒÆ÷
  • nuclear ³ª nuclearis
    ÇÙÀÇ »ý¹°ÀÇ , ¿øÀÚÇÙ (ê«í­ú·)ÀÇ.
  • nuclear-cytoplasmic asynchrony
    ÇÙ-¼¼Æ÷Áúºñµ¿½Ã¼º(ÞªÔÒãÁàõ)
  • outer nuclear layer
    ¹Ù±ù¼¼Æ÷Ãþ
  • outer nuclear layer
    ¿Ü°ú¸³Ãþ, ¹Ù±ùÇÙÃþ
  • outer nuclear layer
    ¹Ù±ùÇÙÃþ
  • progressive nuclear ophthalmoplegia
    ÁøÇ༺ÇÙ¼º¾È±Ù¸¶ºñ.
  • progressive nuclear ophthalmoplegia
    ÁøÇ༺ ÇÙ¼º ¾È±Ù¸¶ºñ(òäú¼àõ ú·àõ äÑÐÉØ¦Ýö)
  • progressive nuclear ophthalmoplegia
    ÁøÇ༺ÇÙ¼º¾È±Ù¸¶ºñ
  • activated complex
    Ȱ¼ºº¹ÇÕ, Ȱ¼ºº¹ÇÕ¹°
  • acyl-plasminogen streptokinase activator complex
    ¾Æ½Ç-Çø®Áî¹Ì³ë°Õ½ºÆ®·¾ÅäŰ³ªÁ¦È°¼ºÁ¦º¹ÇÕü
  • agr complex
    AGR º¹ÇÕü(¡­ÜÜùêô÷)
  • amylase complex with immunoglobulin = macroamylase
    ¸é¿ª±ÛºÒ¸°¾Æ¹Ð¶óÁ¦º¹ÇÕü=¸¶Å©·Î¾Æ¹Ð¶óÁ¦
  • anti-inhibitor coagulation complex
    Ç×¾ïÁ¦Á¦ÀÀ°í°áÇÕü
  • antigen-antibody complex
    Ç׿ø-Ç×üº¹ÇÕü
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • Anterolateral nucleus
    ¾Õ°¡ÂÊÇÙ
    [¿¾ ¿ë¾î] Àü¿ÜÃøÇÙ
  • Anterior paraventricular nucleus
    ¾Õ³ú½Ç°çÇÙ
    [¿¾ ¿ë¾î] Àü½Ç¹æÇÙ
  • Anterior cochlear nucleus
    ¾Õ´ÞÆØÀÌÇÙ
    [¿¾ ¿ë¾î] Àü¿Í¿ì½Å°æÇÙ
  • Anterior trapezoid nucleus
    ¾Õ¸¶¸§¼¶À¯Ã¼ÇÙ
    [¿¾ ¿ë¾î] Àü´ÉÇüüÇÙ
  • Anterior ventral nucleus
    ¾Õ¹èÂÊÇÙ
    [¿¾ ¿ë¾î] Àüº¹ÃøÇÙ
  • Anterior hypothalamic nucleus
    ¾Õ½Ã»óÇϺÎÇÙ
    [¿¾ ¿ë¾î] Àü½Ã»óÇϺÎÇÙ
  • Anteromedial nucleus
    ¾Õ¾ÈÂÊÇÙ
    [¿¾ ¿ë¾î] Àü³»ÃøÇÙ
  • Facial nucleus
    ¾ó±¼½Å°æÇÙ
    [¿¾ ¿ë¾î] ¾È¸é½Å°æÇÙ
  • Superior pontine intermediate reticular nucleus
    À§´Ù¸®³úÁß°£±×¹°ÇÙ
    [¿¾ ¿ë¾î] »ó±³³úÁß°£¸Á»óüÇÙ
  • Superior vestibular nucleus
    À§¾È¶ãÇÙ
    [¿¾ ¿ë¾î] ÀüÁ¤½Å°æ»óÇÙ
  • Superior olivary nucleus
    À§¿Ã¸®ºêÇÙ
    [¿¾ ¿ë¾î] »ó¿Ã¸®ºêÇÙ
  • Nucleus raphe linearis superior
    À§ÁÙ¼Ö±âÇÙ
    [¿¾ ¿ë¾î] »ó¼±ºÀ¼±ÇÙ
  • Nucleus raphe centralis superior
    À§Á߽ɼֱâÇÙ
    [¿¾ ¿ë¾î] »óÁ߽ɺÀ¼±ÇÙ
  • Superior salivatory nucleus
    À§Ä§ºÐºñÇÙ
    [¿¾ ¿ë¾î] »óŸ¾×ÇÙ
  • Nucleus ambiguus
    Àǹ®ÇÙ
    [¿¾ ¿ë¾î] ÀÇÇÙ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 9
HNP hereditary nephritic protein; herniated nucleus pulposus; human neurophysin
IN icterus neonatorum; impetigo neonatorum; incidence; incompatibility number; infundibular nucleus; in...
IPN infantile polyarteritis nodosa; infectious pancreatic necrosis [of trout]; intern progress note; int...
LGN lateral geniculate nucleus; lateral glomerulonephritis
LHN lateral hypothalamic nucleus
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 9
GC Golgi complex
HNC hypothalamo-neurohypophyseal complex
IgA-IC IgA immune complex
IC Immune Complex
ICD Immune Complex Dissociated
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • nucleus isomer
    ÇÙ À̼ºÃ¼
  • nucleus lemnisci lateralis
    ¿ÜÃø ¼¶À¯¶ì ÇÙ
  • nucleus medialis centralis thalami
    ½Ã»ó Á᫐ ³»Ãø ÇÙ
    ´ëºÎºÐÀÌ ½Ã»óÀÇ ³»Ãø ¼öÆÇ¿¡ ÀÖ´Â ¸í·áÇÑ ÇÙÀ¸·Î¼­ »óºÎÀÇ ³»Ãø ÇÙ°ú ÇϺÎÀÇ Èij»Ãø ÇÙ »çÀÌ¿¡ ÀÖ´Ù. ¼±Á¶Ã¼ ¹× ¿îµ¿ ÇÇÁú°ú º¹ÀâÇÏ°Ô ¿¬°áµÇ¾î ÀÖ´Ù.
  • nucleus medialis thalami
    ½Ã»ó ³»Ãø ÇÙ
    ½Ã»ó ³»Ãø ÇÙ Áß °¡Àå Å« ½Å°æ ÇÙ. ¹®ÃøÀÇ ´ë¼¼Æ÷ºÎ¿Í ¹Ì¿ÜÃøÀÇ ¼Ò¼¼Æ÷ºÎ·Î ÀÌ·ç¾îÁö¸ç, ´Ù¸¥ ½Ã»ó ÇÙÀÇ ´ëºÎºÐ°ú ±¤¹üÀ§ÇÑ ¿¬¶ôÀ» °¡Áø´Ù.
  • nucleus motorius nervi trigemini
    »ïÂ÷ ½Å°æ ¿îµ¿ ÇÙ
    »ïÂ÷ ½Å°æÀÇ ¿îµ¿ ¼¶À¯ÀÇ ±â½Ã ÇÙÀ¸·Î¼­, ÁÖÁö°¢ ÇÙ ¹× À̰÷À¸·Î µé¾î°¡´Â Áö°¢±ÙÀÇ ¹Ù·Î ³»Ãø¿¡ ÀÖ´Â ±³ÀÇ ¹èÃøºÎ¿¡ ÀÖ´Ù.
  • nucleus nervi facialis
    ¾È¸é ½Å°æ ÇÙ
    ¾È¸é ½Å°æ ¿îµ¿ ¼¶À¯ÀÇ ±â½Ã ÇÙÀ¸·Î¼­ ¾È¸é Ç¥Á¤±ÙÀÇ ½Å°æÀ» Áö¹èÇÑ´Ù. ¹éÀº ÇϺα³ÀÇ º¹ ¿ÜÃøºÎ¿¡ ÀÖÀ¸¸ç °Å±â¼­ ³ª¿À´Â ¼¶À¯´Â ¿ÜÀü ½Å°æ ÇÙ ÁÖÀ§¿¡¼­ º¹ÀâÇÑ °í¸®¸¦ Çü¼ºÇÑ´Ù. ÀÌ ¸íĪÀº ¶ÇÇÑ ¿îµ¿ ÇÙ, »óŸ¾× ÇÙ ¹× °í¼Ó ÇÙÀ» ÃÑÄªÇØ¼­ »ç¿ëµÈ´Ù.
  • nucleus nervi hypoglossi
    ¼³ÇÏ ½Å°æ ÇÙ
    ¼³ÇÏ ½Å°æÀÇ ±â½Ã ÇÙÀ¸·Î¼­, ÇϿø®ºê À§Ä¡º¸´Ù ¹Ø¿¡¼­ºÎÅÍ ¿¬¼öÀÇ »óºÎ¿¡ À̸£´Â ³»Ãø À¶±âÀÇ Áß½É È¸¹éÁú¿¡ ³»ÁÖ¸¦ Çü¼ºÇÑ´Ù.
  • nucleus nervi trigemini
    »ïÂ÷ ½Å°æ ÇÙ
    »ïÂ÷ ½Å°æÀÇ ÇÙ º¹ÇÕü·Î¼­, ÁÖ°í ±³ ¹× ¿¬¼ö¿¡ Á¸ÀçÇϳª ÁßÁË ¹× »óºÎ °æ¼ö¿¡µµ Á¸ÀçÇÑ´Ù.
  • nucleus nervi vagi
    ¹ÌÁÖ ½Å°æ ÇÙ
    ¹ÌÁÖ ½Å°æÀÇ ±â½Ã ÇÙ ¹× Á¾¸» ÇÙÀ¸·Î¼­, ¿¬¼ö¿¡ ÀÖÀ¸¸ç ¹èÃø ÇÙ, ÀÇÇÙ ¹× °í¼Ó ÇÙÀ¸·Î ÀÌ·ç¾îÁø´Ù.
  • nucleus nigra
    ÈæÇÙ
  • nucleus of lateral genicutate body
    ¿ÜÃø ¹«¸­ ÇÙ, ¿ÜÃø ½½»óü ÇÙ
  • nucleus of medial geniculate body
    ³»Ãø ¹«¸­ ÇÙ
  • nucleus of spinal tract
    ô¼ö·Î ÇÙ
  • nucleus originis accessorious nervi oculomotorii
    µ¡µ¿¾È ½Å°æ ½ÃÀÛ ÇÙ, µ¿¾È ½Å°æ ±â½Ã ÇÙ
  • nucleus originis nervi hypoglossi
    ¼³ÇÏ ½Å°æ ½ÃÀÛ ÇÙ, ¼³ÇÏ ½Å°æ ±â½Ã ÇÙ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
receptor-CD3 complex, antigen, T-cell Molecule composed of the non-covalent association of the T-cell antigen receptor (receptors, antigen, T-cell) with the CD3 complex (antigens, CD3). This association is required for the surface expression and function of both components. The molecule consists of up to seven chains: either the alpha/beta or gamma/delta chains of the T-cell receptor, and four or five chains in the CD3 complex.
(12 Dec 1998)
Ghon's complex Calcification seen in pulmonary parenchyma (usually mid-lung area) and hilar nodes resulting from earlier, usually childhood, infection with tuberculosis.
Synonym: Ghon's complex, Ghon's focus, Ghon's primary lesion.
(05 Mar 2000)
castration complex A child's fear of injury to the genitals by the parent of the same sex as punishment for unconcious guilt over oedipal feelings, fantasied loss of the penis by a female or fear of its actual loss by a male, unconscious fear of injury from those in authority.
Synonym: castration anxiety.
(05 Mar 2000)
caudal pharyngeal complex The ultimobranchial body associated with the embryonic fourth and transitory fifth pharyngeal pouches.
(05 Mar 2000)
vitamin b complex <chemical> A group of water-soluble substances including thiamine, riboflavin, niacin (nicotinic acid), niacinamide (nicotinamide), the vitamin b6 group (including pyridoxine, pyridoxal, pyridoxamine), biotin, pantothenic acid, folic acid, possibly para-aminobenzoic acid, inositol, vitamin b12, and possibly choline.
Chemical name: Vitamin B
(12 Dec 1998)
central complex In an enzyme-catalyzed reaction, the structural complex of the enzyme and all of the enzyme's substrates (or the enzyme with all of the enzyme's products) equivalent to the binary complex for a one-substrate enzyme.
Compare: binary complex, Michaelis complex.
(05 Mar 2000)
glycine cleavage complex A complex of several proteins that catalyze the reversible reaction of glycine with tetrahydrofolate to produce CO2, NH3, and N5,N10-methylenetetrahydrofolate; a deficiency of this enzyme (or one of its subunits) will result in nonketotic hyperglycinaemia.
Synonym: glycine synthase.
(05 Mar 2000)
Golgi complex <cell biology> Intracellular stack of membrane bounded vesicles in which glycosylation and packaging of secreted proteins takes place. Part of the GERL complex.
Synonym: Golgi body, Golgi vesicles, dictyosome (in plants), parabasal body (in flagellate protozoa).
(11 Jan 1998)
membrane attack complex <immunology> A term originally used to refer to the heat labile factor in serum that causes immune cytolysis, the lysis of antibody coated cells and now referring to the entire functionally related system comprising at least 20 distinct serum proteins that is the effector not only of immune cytolysis but also of other biologic functions.
Complement activation occurs by two different sequences, the classic and alternative pathways. The proteins of the classic pathway are termed components of complement and are designated by the symbols C1 through C9.
C1 is a calcium dependent complex of three distinct proteins C1q, C1r and C1s. The proteins of the alternative pathway (collectively referred to as the properdin system) and complement regulatory proteins are known by semisystematic or trivial names. Fragments resulting from proteolytic cleavage of complement proteins are designated with lower case letter suffixes, for example, C3a. Inactivated fragments may be designated with the suffix i, for example C3bi. Activated components or complexes with biological activity are designated by a bar over the symbol for example C1 or C4b, 2a.
The classic pathway is activated by the binding of C1 to classic pathway activators, primarily antigen-antibody complexes containing IgM, IgG1, IgG3, C1q binds to a single IgM molecule or two adjacent IgG molecules.
The alternative pathway can be activated by IgA immune complexes and also by nonimmunologic materials including bacterial endotoxins, microbial polysaccharides and cell walls. Activation of the classic pathway triggers an enzymatic cascade involving C1, C4, C2 and C3, activation of the alternative pathway triggers a cascade involving C3 and factors B, D and P. Both result in the cleavage of C5 and the formation of the membrane attack complex.
Complement activation also results in the formation of many biologically active complement fragments that act as anaphylatoxins, opsonins or chemotactic factors.
(05 Jan 1998)
charge transfer complex A complex between two organic molecules in which an electron from one (the donor) is transferred to the other (the acceptor), becoming generally distributed throughout the latter; subsequent transfer of a hydrogen atom completes the reduction of the acceptor; such complex's are generally highly coloured and may be so observed, a network of hydrogen bridges at the catalytic centre of certain proteases.
Synonym: charge transfer system.
(05 Mar 2000)
periodontitis complex Vertical resorption of the alveolar process with pockets of uneven depth on adjacent teeth, and with traumatic occlusion as a factor.
(05 Mar 2000)
ribosome-lamella complex A cylindrical cytoplasmic inclusion composed of concentrically arranged sheets of membranes alternating with rows of ribosomes; characteristic of the hairy cell in leukaemic reticuloendotheliosis.
(05 Mar 2000)
persecution complex A feeling that others have evil designs against one's well-being.
(05 Mar 2000)
met repressor operator complex Repressor protein, 104 residues, product of the metJ gene, which regulates methionine biosynthesis in E. Coli. Dimeric molecules bind to adjacent sites 8 base pairs apart on the DNA, sequence recognition is by interaction between antiparallel strands of protein and the major groove of the B form DNA duplex.
(18 Nov 1997)
Meyenburg's complex Clusters of small bile ducts occurring in polycystic livers, separate from the portal areas.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 9
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 9
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 9
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 9
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 9
ÅëÇÕ°Ë»ö ¿Ï·á